CAD and breast cancer: In BC, CPS triggers the proteasomal degradation of tNOX, leading to the inhibition of NAD+-dependent SIRT1 deacetylase and the enhancement of c-Myc and p53 that suppresses G1 cyclin-dependent kinase activation and triggers cell cycle arrest [14].